Skip to main content
SpringerLink
Log in

Step-up strategy better choice than step-down in dyspepsia

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. van Marrewijk CJ, Mujakovic S, Fransen GAJ, Numans ME, de Wit NJ, Muris JWM, van Oijen MGH, Jansen JBMJ, Grobbee DE, Knottnerus JA, Laheij RJ.Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 373: 215-225, No. 9659, 17 Jan 2009

  2. Veldhuyzen van Zanten S.Dyspepsia and reflux in primary care: rough DIAMOND of a trial. Lancet 373: 187-188, No. 9659, 17 Jan 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Step-up strategy better choice than step-down in dyspepsia. Pharmacoecon. Outcomes News 570, 6 (2009). https://doi.org/10.2165/00151234-200905700-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905700-00015

Keywords

Search

Navigation